Skip to main content
Erschienen in: Digestive Diseases and Sciences 5/2020

22.10.2019 | Original Article

Patients with Alcoholic Liver Disease Have Worse Functional Status at Time of Liver Transplant Registration and Greater Waitlist and Post-transplant Mortality Which Is Compounded by Older Age

verfasst von: Patrick McCabe, Artin Galoosian, Robert J. Wong

Erschienen in: Digestive Diseases and Sciences | Ausgabe 5/2020

Einloggen, um Zugang zu erhalten

Abstract

Background

Worse functional status correlates with increased mortality on the liver transplant (LT) waitlist. Whether functional status affects LT outcomes equally across cirrhosis etiologies is unclear.

Aims

We evaluate the impact of functional status on waitlist and post-LT mortality stratified by etiology and age.

Methods

Functional status among US adults from 2005 to 2017 United Network for Organ Sharing LT registry data was retrospectively evaluated using Karnofsky Performance Status Score (KPS-1 = functional status 80–100%, KPS-2 = 60–70%, KPS-3 = 40–50%, KPS-4 = 10–30%). Waitlist and post-LT survival were stratified by KPS and cirrhosis etiology, including alcoholic liver disease (ALD), nonalcoholic steatohepatitis (NASH), hepatitis C (HCV), and HCV/ALD, and evaluated using Kaplan–Meier and multivariate Cox proportional hazard models.

Results

Among 94,201 waitlist registrants (69.4% men, 39.5% HCV, 26.7% ALD, 23.2% NASH), ALD patients had worse functional status compared to HCV (KPS-4: 17.2% vs. 8.3%, p < 0.001). Worse functional status at time of waitlist registration was associated with higher 90-day waitlist mortality with the greatest effect in ALD (KPS-4 vs. KPS-1: ALD HR 2.16, 95% CI 1.83–2.55; HCV HR 2.17, 95% CI 1.87–2.51). Similar trends occurred in 5-year post-LT survival with ALD patients the most harmed. Compared to patients < 50 years, patients ≥ 65 years had increased waitlist mortality at 90-days if they had HCV or HCV/ALD, and 5-year post-LT mortality regardless of cirrhosis etiology with ALD patients most severely affected.

Conclusions

In a retrospective cohort study of patients, US ALD patients had disparately worse functional status at time of LT waitlist registration. Worse functional status correlated with higher risk of waitlist and post-LT mortality, affecting ALD and HCV patients the most.
Literatur
1.
Zurück zum Zitat Lai JC, Dodge JL, Sen S, Covinsky K, Feng S. Functional decline in patients with cirrhosis awaiting liver transplantation: results from the functional assessment in liver transplantation (FrAILT) study. Hepatology. 2016;63:574–580.CrossRef Lai JC, Dodge JL, Sen S, Covinsky K, Feng S. Functional decline in patients with cirrhosis awaiting liver transplantation: results from the functional assessment in liver transplantation (FrAILT) study. Hepatology. 2016;63:574–580.CrossRef
2.
Zurück zum Zitat McCabe P, Wong RJ. More severe deficits in functional status associated with higher mortality among adults awaiting liver transplantation. Clin Transplant. 2018;32:e13346.CrossRef McCabe P, Wong RJ. More severe deficits in functional status associated with higher mortality among adults awaiting liver transplantation. Clin Transplant. 2018;32:e13346.CrossRef
3.
Zurück zum Zitat Orman ES, Ghabril M, Chalasani N. Poor performance status is associated with increased mortality in patients with cirrhosis. Clin Gastroenterol Hepatol. 2016;14(8):1189.e1–1195.e1.CrossRef Orman ES, Ghabril M, Chalasani N. Poor performance status is associated with increased mortality in patients with cirrhosis. Clin Gastroenterol Hepatol. 2016;14(8):1189.e1–1195.e1.CrossRef
4.
Zurück zum Zitat Samoylova ML, Covinsky KE, Haftek M, Kuo S, Roberts JP, Lai JC. Disability in patients with end-stage liver disease: results from the functional assessment in liver transplantation study. Liver Transpl. 2017;23:292–298.CrossRef Samoylova ML, Covinsky KE, Haftek M, Kuo S, Roberts JP, Lai JC. Disability in patients with end-stage liver disease: results from the functional assessment in liver transplantation study. Liver Transpl. 2017;23:292–298.CrossRef
5.
Zurück zum Zitat Tapper EB, Finkelstein D, Mittleman MA, Piatkowski G, Lai M. Standard assessments of frailty are validated predictors of mortality in hospitalized patients with cirrhosis. Hepatology. 2015;62:584–590.CrossRef Tapper EB, Finkelstein D, Mittleman MA, Piatkowski G, Lai M. Standard assessments of frailty are validated predictors of mortality in hospitalized patients with cirrhosis. Hepatology. 2015;62:584–590.CrossRef
6.
Zurück zum Zitat Wang CW, Lebsack A, Chau S, Lai JC. The range and reproducibility of the liver frailty index. Liver Transpl. 2019;25:841–847.CrossRef Wang CW, Lebsack A, Chau S, Lai JC. The range and reproducibility of the liver frailty index. Liver Transpl. 2019;25:841–847.CrossRef
7.
Zurück zum Zitat Karnofsky DA, Burchenal J. The clinical evaluation of chemotherapeutic agents in cancer. In: MacLeod CM, ed. evaluation of chemotherapeutic agents. New York: Columbia University Press; 1949. Karnofsky DA, Burchenal J. The clinical evaluation of chemotherapeutic agents in cancer. In: MacLeod CM, ed. evaluation of chemotherapeutic agents. New York: Columbia University Press; 1949.
8.
Zurück zum Zitat Oken MM, Creech RH, Tormey DC, et al. Toxicity and response criteria of the Eastern Cooperative Oncology Group. Am J Clin Oncol. 1982;5:649–655.CrossRef Oken MM, Creech RH, Tormey DC, et al. Toxicity and response criteria of the Eastern Cooperative Oncology Group. Am J Clin Oncol. 1982;5:649–655.CrossRef
9.
Zurück zum Zitat Wong RJ, Aguilar M, Cheung R, et al. Nonalcoholic steatohepatitis is the second leading etiology of liver disease among adults awaiting liver transplantation in the United States. Gastroenterology. 2015;148:547–555.CrossRef Wong RJ, Aguilar M, Cheung R, et al. Nonalcoholic steatohepatitis is the second leading etiology of liver disease among adults awaiting liver transplantation in the United States. Gastroenterology. 2015;148:547–555.CrossRef
10.
Zurück zum Zitat Wong RJ, Cheung R, Ahmed A. Nonalcoholic steatohepatitis is the most rapidly growing indication for liver transplantation in patients with hepatocellular carcinoma in the US. Hepatology. 2014;59:2188–2195.CrossRef Wong RJ, Cheung R, Ahmed A. Nonalcoholic steatohepatitis is the most rapidly growing indication for liver transplantation in patients with hepatocellular carcinoma in the US. Hepatology. 2014;59:2188–2195.CrossRef
11.
Zurück zum Zitat Thuluvath PJ, Thuluvath AJ, Savva Y. Karnofsky performance status before and after liver transplantation predicts graft and patient survival. J Hepatol. 2018;69:818–825.CrossRef Thuluvath PJ, Thuluvath AJ, Savva Y. Karnofsky performance status before and after liver transplantation predicts graft and patient survival. J Hepatol. 2018;69:818–825.CrossRef
12.
Zurück zum Zitat Malinis MF, Chen S, Allore HG, Quagliarello VJ, et al. Outcomes among older adult liver transplantation recipients in the model of end stage liver disease (MELD) era. Ann Transplant. 2014;19:478–487.CrossRef Malinis MF, Chen S, Allore HG, Quagliarello VJ, et al. Outcomes among older adult liver transplantation recipients in the model of end stage liver disease (MELD) era. Ann Transplant. 2014;19:478–487.CrossRef
13.
Zurück zum Zitat McCabe P, Gish RG, Cheung R, Wong RJ. More severe deficits in performance status at time of liver transplant is associated with significantly higher risk of death following liver transplantation. J Clin Gastroenterol. 2019;53:e392–e399.CrossRef McCabe P, Gish RG, Cheung R, Wong RJ. More severe deficits in performance status at time of liver transplant is associated with significantly higher risk of death following liver transplantation. J Clin Gastroenterol. 2019;53:e392–e399.CrossRef
14.
Zurück zum Zitat Thuluvath PJ, Hanish S, Savva Y. Waiting list mortality and transplant rates for NASH cirrhosis when compared with cryptogenic, alcoholic, or AIH cirrhosis. Transplantation. 2019;103:113–121.CrossRef Thuluvath PJ, Hanish S, Savva Y. Waiting list mortality and transplant rates for NASH cirrhosis when compared with cryptogenic, alcoholic, or AIH cirrhosis. Transplantation. 2019;103:113–121.CrossRef
15.
Zurück zum Zitat Goldberg D, French B, Abt P, Feng S, Cameron AM. Increasing disparity in waitlist mortality rates with increased model for end-stage liver disease scores for candidates with hepatocellular carcinoma versus candidates without hepatocellular carcinoma. Liver Transpl. 2012;18:434–443.CrossRef Goldberg D, French B, Abt P, Feng S, Cameron AM. Increasing disparity in waitlist mortality rates with increased model for end-stage liver disease scores for candidates with hepatocellular carcinoma versus candidates without hepatocellular carcinoma. Liver Transpl. 2012;18:434–443.CrossRef
16.
Zurück zum Zitat Trivedi HD, Tapper EB. Interventions to improve physical function and prevent adverse events in cirrhosis. Gastroenterology Report. 2018;6:13–20.CrossRef Trivedi HD, Tapper EB. Interventions to improve physical function and prevent adverse events in cirrhosis. Gastroenterology Report. 2018;6:13–20.CrossRef
17.
Zurück zum Zitat Lucey MR. Liver transplantation in patients with alcoholic liver disease. Liver Transpl. 2011;17:751–759.CrossRef Lucey MR. Liver transplantation in patients with alcoholic liver disease. Liver Transpl. 2011;17:751–759.CrossRef
18.
Zurück zum Zitat Adachi J, Asano M, Ueno Y, et al. Alcoholic muscle disease and biomembrane perturbations (review). J Nutr Biochem. 2003;14:616–625.CrossRef Adachi J, Asano M, Ueno Y, et al. Alcoholic muscle disease and biomembrane perturbations (review). J Nutr Biochem. 2003;14:616–625.CrossRef
19.
Zurück zum Zitat Sacanella E, Fernández-Solà J, Cofan M, et al. Chronic alcoholic myopathy: diagnostic clues and relationship with other ethanol-related diseases. QJM. 1995;88:811–817.PubMed Sacanella E, Fernández-Solà J, Cofan M, et al. Chronic alcoholic myopathy: diagnostic clues and relationship with other ethanol-related diseases. QJM. 1995;88:811–817.PubMed
20.
Zurück zum Zitat Marroni CA, Fleck AM, Fernandes SA, et al. Liver transplantation and alcoholic liver disease: history, controversies, and considerations. World J Gastroenterol. 2018;24:2785–2805.CrossRef Marroni CA, Fleck AM, Fernandes SA, et al. Liver transplantation and alcoholic liver disease: history, controversies, and considerations. World J Gastroenterol. 2018;24:2785–2805.CrossRef
21.
Zurück zum Zitat Grat M, Lewandowski Z, Grąt K, et al. Negative outcomes after liver transplantation in patients with alcoholic liver disease beyond the fifth post-transplant year. Clin Transplant. 2014;28:1112–1120.CrossRef Grat M, Lewandowski Z, Grąt K, et al. Negative outcomes after liver transplantation in patients with alcoholic liver disease beyond the fifth post-transplant year. Clin Transplant. 2014;28:1112–1120.CrossRef
22.
Zurück zum Zitat Galant LH, Forgiarini Junior LA, Dias AS, Marroni CA. Functional status, respiratory muscle strength, and quality of life in patients with cirrhosis. Brazilian Journal of Physical Therapy. 2012;16:30–34.CrossRef Galant LH, Forgiarini Junior LA, Dias AS, Marroni CA. Functional status, respiratory muscle strength, and quality of life in patients with cirrhosis. Brazilian Journal of Physical Therapy. 2012;16:30–34.CrossRef
23.
Zurück zum Zitat Bryce CL, Angus DC, Arnold RM, et al. Sociodemographic differences in early access to liver transplantation services. Am J Transplant. 2009;9:2092–2101.CrossRef Bryce CL, Angus DC, Arnold RM, et al. Sociodemographic differences in early access to liver transplantation services. Am J Transplant. 2009;9:2092–2101.CrossRef
24.
Zurück zum Zitat Shah ND, Cots MV, Zhang C, Zahiragic N. Worldwide lack of early referral of patients with alcoholic liver disease: results of the global alcoholic liver disease survey (GLADIS). J Hepatology. 2017;66:S107–S108.CrossRef Shah ND, Cots MV, Zhang C, Zahiragic N. Worldwide lack of early referral of patients with alcoholic liver disease: results of the global alcoholic liver disease survey (GLADIS). J Hepatology. 2017;66:S107–S108.CrossRef
25.
Zurück zum Zitat Ursic-Bedoya J, Faure S, Donnadieu-Rigole H, Pageaux GP. Liver transplantation for alcoholic liver disease: lessons learned and unresolved issues. World J Gastroenterol. 2015;21:10994–11002.CrossRef Ursic-Bedoya J, Faure S, Donnadieu-Rigole H, Pageaux GP. Liver transplantation for alcoholic liver disease: lessons learned and unresolved issues. World J Gastroenterol. 2015;21:10994–11002.CrossRef
26.
Zurück zum Zitat dos Santos DC, Limongi V, Oliveira da Silva AM, et al. Evaluation of functional status, pulmonary capacity, body composition, and quality of life of end-stage liver disease patients who are candidates for liver surgery. Transplant Proc. 2014;46:1771–1774.CrossRef dos Santos DC, Limongi V, Oliveira da Silva AM, et al. Evaluation of functional status, pulmonary capacity, body composition, and quality of life of end-stage liver disease patients who are candidates for liver surgery. Transplant Proc. 2014;46:1771–1774.CrossRef
27.
Zurück zum Zitat Duarte-Rojo A, et al. Exercise and physical activity for patients with end-stage liver disease: Improving functional status and sarcopenia while on the transplant waiting list. Liver Transpl. 2018;24:122–139.CrossRef Duarte-Rojo A, et al. Exercise and physical activity for patients with end-stage liver disease: Improving functional status and sarcopenia while on the transplant waiting list. Liver Transpl. 2018;24:122–139.CrossRef
28.
Zurück zum Zitat Mizuno Y, et al. Changes in muscle strength and six-minute walk distance before and after living donor liver transplantation. Transplant Proc. 2016;48:3348–3355.CrossRef Mizuno Y, et al. Changes in muscle strength and six-minute walk distance before and after living donor liver transplantation. Transplant Proc. 2016;48:3348–3355.CrossRef
29.
Zurück zum Zitat Ow MM, et al. Impaired functional capacity in potential liver transplant candidates predicts short-term mortality before transplantation. Liver Transpl. 2014;20:1081–1088.CrossRef Ow MM, et al. Impaired functional capacity in potential liver transplant candidates predicts short-term mortality before transplantation. Liver Transpl. 2014;20:1081–1088.CrossRef
30.
Zurück zum Zitat Prentis JM, et al. Submaximal cardiopulmonary exercise testing predicts 90-day survival after liver transplantation. Liver Transpl. 2012;18:152–159.CrossRef Prentis JM, et al. Submaximal cardiopulmonary exercise testing predicts 90-day survival after liver transplantation. Liver Transpl. 2012;18:152–159.CrossRef
31.
Zurück zum Zitat Tandon P, Ney M, Irwin I, Ma M, et al. Severe muscle depletion in patients on the liver transplant wait list: its prevalence and independent prognostic value. Liver Transpl. 2012;18:1209–1216.CrossRef Tandon P, Ney M, Irwin I, Ma M, et al. Severe muscle depletion in patients on the liver transplant wait list: its prevalence and independent prognostic value. Liver Transpl. 2012;18:1209–1216.CrossRef
32.
Zurück zum Zitat Wang CW, Feng S, Covinsky KE, et al. A comparison of muscle function, mass, and quality in liver transplant candidates: results from the functional assessment in liver transplantation study. Transplantation. 2016;100:1692–1698.CrossRef Wang CW, Feng S, Covinsky KE, et al. A comparison of muscle function, mass, and quality in liver transplant candidates: results from the functional assessment in liver transplantation study. Transplantation. 2016;100:1692–1698.CrossRef
33.
Zurück zum Zitat Bolondi G, Mocchegiani F, Montalti R, Nicolini D, Vivarelli M, De Pietri L. Predictive factors of short term outcome after liver transplantation: a review. World J Gastroenterol. 2016;22:5936–5949.CrossRef Bolondi G, Mocchegiani F, Montalti R, Nicolini D, Vivarelli M, De Pietri L. Predictive factors of short term outcome after liver transplantation: a review. World J Gastroenterol. 2016;22:5936–5949.CrossRef
34.
Zurück zum Zitat Schag CC, Heinrich RL, Ganz PA. Karnofsky performance status revisited: reliability, validity, and guidelines. J Clin Oncol. 1984;2:187–193.CrossRef Schag CC, Heinrich RL, Ganz PA. Karnofsky performance status revisited: reliability, validity, and guidelines. J Clin Oncol. 1984;2:187–193.CrossRef
35.
Zurück zum Zitat Mor V, Laliberte L, Morris JN, Wiemann M. The Karnofsky performance status scale. An examination of its reliability and validity in a research setting. Cancer. 1984;53:2002–2007.CrossRef Mor V, Laliberte L, Morris JN, Wiemann M. The Karnofsky performance status scale. An examination of its reliability and validity in a research setting. Cancer. 1984;53:2002–2007.CrossRef
36.
Zurück zum Zitat Dunn MA, Josbeno DA, Schmotzer AR, et al. The gap between clinically assessed physical performance and objective physical activity in liver transplant candidates. Liver Transpl. 2016;22:1324–1332.CrossRef Dunn MA, Josbeno DA, Schmotzer AR, et al. The gap between clinically assessed physical performance and objective physical activity in liver transplant candidates. Liver Transpl. 2016;22:1324–1332.CrossRef
37.
Zurück zum Zitat Wang CW, Lai JC. Reporting functional status in UNOS: the weakness of the Karnofsky performance status scale. Clin Transpl 2017. 31. Wang CW, Lai JC. Reporting functional status in UNOS: the weakness of the Karnofsky performance status scale. Clin Transpl 2017. 31.
38.
Zurück zum Zitat Lai JC, Covinsky KE, McCulloch CE, Feng S. The liver frailty index improves mortality prediction of the subjective clinician assessment in patients with cirrhosis. Am J Gastroenterol. 2018;113:235–242.CrossRef Lai JC, Covinsky KE, McCulloch CE, Feng S. The liver frailty index improves mortality prediction of the subjective clinician assessment in patients with cirrhosis. Am J Gastroenterol. 2018;113:235–242.CrossRef
39.
Zurück zum Zitat Lai JC, Covinsky KE, Hayssen H, et al. Author response to: clinical assessments of health status as a potential marker to identify patients who are too sick to undergo transplantation. Liver Int. 2016;36:611.CrossRef Lai JC, Covinsky KE, Hayssen H, et al. Author response to: clinical assessments of health status as a potential marker to identify patients who are too sick to undergo transplantation. Liver Int. 2016;36:611.CrossRef
Metadaten
Titel
Patients with Alcoholic Liver Disease Have Worse Functional Status at Time of Liver Transplant Registration and Greater Waitlist and Post-transplant Mortality Which Is Compounded by Older Age
verfasst von
Patrick McCabe
Artin Galoosian
Robert J. Wong
Publikationsdatum
22.10.2019
Verlag
Springer US
Erschienen in
Digestive Diseases and Sciences / Ausgabe 5/2020
Print ISSN: 0163-2116
Elektronische ISSN: 1573-2568
DOI
https://doi.org/10.1007/s10620-019-05891-1

Weitere Artikel der Ausgabe 5/2020

Digestive Diseases and Sciences 5/2020 Zur Ausgabe

Stanford Multidisciplinary Seminars

Let’s (Not) Twist Again

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Notfall-TEP der Hüfte ist auch bei 90-Jährigen machbar

26.04.2024 Hüft-TEP Nachrichten

Ob bei einer Notfalloperation nach Schenkelhalsfraktur eine Hemiarthroplastik oder eine totale Endoprothese (TEP) eingebaut wird, sollte nicht allein vom Alter der Patientinnen und Patienten abhängen. Auch über 90-Jährige können von der TEP profitieren.

Niedriger diastolischer Blutdruck erhöht Risiko für schwere kardiovaskuläre Komplikationen

25.04.2024 Hypotonie Nachrichten

Wenn unter einer medikamentösen Hochdrucktherapie der diastolische Blutdruck in den Keller geht, steigt das Risiko für schwere kardiovaskuläre Ereignisse: Darauf deutet eine Sekundäranalyse der SPRINT-Studie hin.

Bei schweren Reaktionen auf Insektenstiche empfiehlt sich eine spezifische Immuntherapie

Insektenstiche sind bei Erwachsenen die häufigsten Auslöser einer Anaphylaxie. Einen wirksamen Schutz vor schweren anaphylaktischen Reaktionen bietet die allergenspezifische Immuntherapie. Jedoch kommt sie noch viel zu selten zum Einsatz.

Therapiestart mit Blutdrucksenkern erhöht Frakturrisiko

25.04.2024 Hypertonie Nachrichten

Beginnen ältere Männer im Pflegeheim eine Antihypertensiva-Therapie, dann ist die Frakturrate in den folgenden 30 Tagen mehr als verdoppelt. Besonders häufig stürzen Demenzkranke und Männer, die erstmals Blutdrucksenker nehmen. Dafür spricht eine Analyse unter US-Veteranen.

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.